Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known if giving cladribine once a day is more
effective than giving cladribine once a week in patients with hairy cell leukemia.
PURPOSE: Randomized phase III trial to compare the effectiveness of cladribine given once a
day to cladribine given once a week in treating patients with hairy cell leukemia.